Belzutifan in Von Hippel-Lindau Syndrome and Renal Cell Carcinoma: Mechanisms, Clinical Evidence, and Future Directions
Cureus · 16.05.2026
DOI: 10.7759/cureus.108967 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 16.05.2026. Verfasst von Jooah Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: General Internal Medicine, Gongju Public Health Center, Gongju, KOR. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Internal Medicine, Gongju Public Health Center, Gongju, KOR.
- Internal Medicine, Sargodha Medical College, Sargodha, PAK.
- Internal Medicine, Kasturba Medical College (KMC), Manipal, IND.
- Internal Medicine, SRM Medical College and Research Center, Chennai, IND.
- Internal Medicine, Subharti Medical College, Meerut, IND.
- Internal Medicine, Shalamar Medical and Dental College, Lahore, PAK.
Zitieren
APA
Park, J., Arshad, H., Khan, S., Vinod, N. P., Goel, R., Vats, D., & Arshad, I. (2026). Belzutifan in Von Hippel-Lindau Syndrome and Renal Cell Carcinoma: Mechanisms, Clinical Evidence, and Future Directions. Cureus. https://doi.org/10.7759/cureus.108967
Vancouver
Park J, Arshad H, Khan S, Vinod NP, Goel R, Vats D, et al. Belzutifan in Von Hippel-Lindau Syndrome and Renal Cell Carcinoma: Mechanisms, Clinical Evidence, and Future Directions. Cureus. 2026. doi:10.7759/cureus.108967
BibTeX
@article{Park2026,
author = {Park, Jooah and Arshad, Heena and Khan, Sharib and Vinod, Neha Pillai and Goel, Riya and Vats, Divyansh and Arshad, Inamullah},
title = {Belzutifan in Von Hippel-Lindau Syndrome and Renal Cell Carcinoma: Mechanisms, Clinical Evidence, and Future Directions},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.108967}
}
EUVIMED